A pilot case-control study exploring the association of the XPC Lys939Gln (rs2228001) polymorphism and metabolic risk factors with pancreatic cancer in an Algerian cohort
Archives of Biological Sciences · 2026 · 78 (2) · 143-149
DOI: 10.2298/abs260412008h ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Archives of Biological Sciences, 2026. Verfasst von Imene Hamiouda und 7 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The role of DNA repair gene polymorphisms in pancreatic cancer susceptibility remains insufficiently characterized, particularly in North African populations. This study investigated the association between the XPC Lys939Gln (rs2228001) polymorphism and pancreatic cancer risk in an Algerian cohort, alongside key metabolic risk factors. This exploratory hospital-based case-control study included 40 patients with histologically confirmed pancreatic cancer and 120 age- and sex-matched controls. Genotyping was performed using PCR-RFLP. Associations were evaluated using logistic regression models adjusted for demographic and metabolic variables. Given the limited sample size, the study was not powered to detect modest genetic effects. No statistically significant association was observed between XPC rs2228001 and pancreatic cancer risk under dominant, recessive, or allelic models (adjusted OR=1.22, 95% CI: 0.27-5.52; P=0.801). Type 2 diabetes mellitus was more frequent among cases and was associated with increased risk (OR=3.48, 95% CI: 1.24-9.77; P=0.018), although this finding should be interpreted with caution due to the exploratory design and limited sample size. The lower BMI observed in cases likely reflects disease-related weight loss. Under the constraints of this exploratory pilot investigation, no statistically detectable association was observed for the XPC rs2228001 variant. These findings are preliminary and should be considered hypothesis-generating. Larger, well-designed studies are required to clarify the interplay between genetic variation and metabolic factors in pancreatic cancer susceptibility.
Zitieren
APA
Hamiouda, I., Laouar, R., Salhi, C., Chellat-Rezgoun, D., Khenchoul, Y., Magra, K., Sifi, K., & Satta, D. (2026). A pilot case-control study exploring the association of the XPC Lys939Gln (rs2228001) polymorphism and metabolic risk factors with pancreatic cancer in an Algerian cohort. Archives of Biological Sciences, 78(2), 143-149. https://doi.org/10.2298/abs260412008h
Vancouver
Hamiouda I, Laouar R, Salhi C, Chellat-Rezgoun D, Khenchoul Y, Magra K, et al. A pilot case-control study exploring the association of the XPC Lys939Gln (rs2228001) polymorphism and metabolic risk factors with pancreatic cancer in an Algerian cohort. Archives of Biological Sciences. 2026;78(2):143-149. doi:10.2298/abs260412008h
BibTeX
@article{Hamiouda2026,
author = {Hamiouda, Imene and Laouar, Rania and Salhi, Choubeila and Chellat-Rezgoun, Djalila and Khenchoul, Youcef and Magra, Khaoula and Sifi, Karima and Satta, Dalila},
title = {A pilot case-control study exploring the association of the XPC Lys939Gln (rs2228001) polymorphism and metabolic risk factors with pancreatic cancer in an Algerian cohort},
journal = {Archives of Biological Sciences},
year = {2026},
volume = {78},
number = {2},
pages = {143--149},
doi = {10.2298/abs260412008h}
}
EUVIMED